Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
The Journal of Rheumatology|September 12, 2008
Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritisWouter H Bos, Geertje M Bartelds, Gerrit Jan Wolbink, et al.
Expert Opinion on Drug Safety|August 10, 2022
Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)Merel de Boer, Helen R Gosselt, Jurriaan Jansen, et al.
Arthritis Research & Therapy|April 17, 2021
Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trialsBernard Combe, Yannick Allanore, Rieke Alten, et al.
Rheumatology International|June 29, 2020
Current understanding and future perspectives of brain-heart-kidney axis in psoriatic arthritisGeorge Markousis-Mavrogenis, Michael T Nurmohamed, Loukia Koutsogeorgopoulou, et al.
Annals of the Rheumatic Diseases|May 23, 2012
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practiceVivian P Bykerk, Andrew J K Ostör, José Alvaro-Gracia, et al.
Arthritis Research & Therapy|September 16, 2019
Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trialHenriëtte M Y de Jong, Leonieke J J van Mens, Michael T Nurmohamed, et al.
Annals of the Rheumatic Diseases|April 17, 2016
Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapyFleur M van der Valk, Sophie J Bernelot Moens, Simone L Verweij, et al.
Clinical Rheumatology|January 22, 2015
Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practiceVivian P Bykerk, Andrew J K Östör, José Alvaro-Gracia, et al.
Arthritis Care & Research|October 4, 2016
Do Short and Sustained Periods of American College of Rheumatology/European League Against Rheumatism Remission Predict Functional and Radiographic Outcome in Early Rheumatoid Arthritis Patients With Low Overall Damage Progression?Nicole P C Konijn, Lilian H D van Tuyl, Maarten Boers, et al.
Arthritis Research & Therapy|March 10, 2012
Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitisSalima F E van Weely, J Christiaan van Denderen, Martijn P M Steultjens, et al.
Pageof 18